Going Global Is Not About Finding Distributors — It’s About Building a Growth System
When virtually every Chinese MedTech company is talking about going global, the question is no longer whether to internationalize — it's how. Attending Medica, signing distributors, and securing registrations are necessary steps, but without a coherent system behind them, they produce isolated orders rather than durable market presence. This article examines the structural blind spots most commonly found in early-stage internationalization efforts, argues why the CEO must own the strategy, and outlines what a self-evolving international growth system actually looks like in practice.